Clinical Trial Update: A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant therapy study for high-risk locally advanced oral squamous cell carcinoma completed, investigating Bio-C/T followed by Bio-R/T.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• Bio-C/T
• Bio-R/T

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Oral Cancer | Phase 2 | Status: COMPLETED